Updated Efficacy and Safety of Lenvatinib Plus Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Advanced Endometrial Cancer: Study 309/KEYNOTE-775
Dr Domenica Lorusso reviews data updates from KEYNOTE-775 that were recently presented at the European Society for Medical Oncology (ESMO) Congress 2022.
The Future of Endometrial Cancer Treatment
Experts give insight on what they are looking forward to in the endometrial cancer space.
A Look at Surgical Innovations in EC
Nicoletta Colombo, MD, PhD, reviews surgical advancements in endometrial cancer.
Novel Targets of Interest in EC
Experts in endometrial cancer comment on novel targets of interest that are currently being investigated.
Insight on Ongoing Trials in EC
Key opinion leaders take a look at the evolving treatment landscape in endometrial cancer, discussing ongoing trials in the space.
Incorporating Molecular Features into Choosing Adjuvant Therapy
Experts discuss the importance of incorporating molecular features into the selection of adjuvant treatment.
Therapeutic Sequencing in Endometrial Cancer
Experts in endometrial cancer comment on therapeutic sequencing in endometrial cancer.
Managing AEs With Pembrolizumab and Lenvatinib
Key opinion leaders emphasize the importance of the management of adverse events in using pembrolizumab and lenvatinib.
Experience in Using Pembrolizumab + Lenvatinib in Advanced Endometrial Cancer
Experts give insight on their clinical use of pembrolizumab-lenvatinib. They highlight dose adjustments and the importance of the increased knowledge of adverse events.
A Discussion on the Study 309/KEYNOTE-775 Data
Key opinion leaders discuss the presented data from Study 309/KEYNOTE-775, highlighting patient reported outcomes, safety, and dosing.
Results from Study 309/KEYNOTE-775
Vicky Makker, MD, presents the results from Study 309/KEYNOTE-775, as well as key safety findings.
Study 309/KEYNOTE-775 Trial Design
Vicky Makker, MD, walks through the trial design of Study 309/KEYNOTE-775.
Therapeutic Approaches in Endometrial Cancer
Experts review optimal approaches to treatment in advanced endometrial cancer, touching on clinical trial data.
Biomarker Testing and Multidisciplinary Approaches in EC
Key opinion leaders share their thoughts on biomarker testing and multidisciplinary approaches for endometrial cancer at their institutions globally.
Heterogeneity of Endometrial Cancer
Experts in gynecologic cancer discuss the heterogeneity of endometrial cancer..
Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care
Dr Habib on Developments in Palliative Care For Patients With Cancer
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC
Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations
2 Clarke Drive Cranbury, NJ 08512